(19 Dec 2020) Sofosbuvir/daclatasvir-did not significantly alleviate symptoms after 7 days of treatment compared with control
Sofosbuvir and daclatasvir for the treatment of COVID-19 outpatients: a double-blind, randomized controlled trial https://doi.org/10.1093/jac/dkaa501 IRCT20200403046926N1- Between 8 April 2020 and 19 May 2020, 55 patients were recruited and allocated to either the sofosbuvir/daclatasvir treatment arm (n = 27) or… Continue reading "(19 Dec 2020) Sofosbuvir/daclatasvir-did not significantly alleviate symptoms after 7 days of treatment compared with control"